232 related articles for article (PubMed ID: 15203317)
21. Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome.
Fierro MT; Comessatti A; Quaglino P; Ortoncelli M; Osella Abate S; Ponti R; Novelli M; Bernengo MG
Dermatology; 2006; 213(4):284-92. PubMed ID: 17135733
[TBL] [Abstract][Full Text] [Related]
22. Inhibition by IL-12 and IFN-alpha of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells.
Iellem A; Colantonio L; Bhakta S; Sozzani S; Mantovani A; Sinigaglia F; D'Ambrosio D
Eur J Immunol; 2000 Apr; 30(4):1030-9. PubMed ID: 10760790
[TBL] [Abstract][Full Text] [Related]
23. Roxithromycin downregulates production of CTACK/CCL27 and MIP-3α/CCL20 from epidermal keratinocytes.
Karakawa M; Komine M; Tamaki K; Ohtsuki M
Arch Dermatol Res; 2010 Dec; 302(10):763-7. PubMed ID: 20625754
[TBL] [Abstract][Full Text] [Related]
24. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells.
Campbell JJ; Haraldsen G; Pan J; Rottman J; Qin S; Ponath P; Andrew DP; Warnke R; Ruffing N; Kassam N; Wu L; Butcher EC
Nature; 1999 Aug; 400(6746):776-80. PubMed ID: 10466728
[TBL] [Abstract][Full Text] [Related]
25. Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo.
Biedermann T; Schwärzler C; Lametschwandtner G; Thoma G; Carballido-Perrig N; Kund J; de Vries JE; Rot A; Carballido JM
Eur J Immunol; 2002 Nov; 32(11):3171-80. PubMed ID: 12555662
[TBL] [Abstract][Full Text] [Related]
26. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
[TBL] [Abstract][Full Text] [Related]
27. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.
Vestergaard C; Bang K; Gesser B; Yoneyama H; Matsushima K; Larsen CG
J Invest Dermatol; 2000 Oct; 115(4):640-6. PubMed ID: 10998136
[TBL] [Abstract][Full Text] [Related]
28. CC chemokine ligand 17 in periodontal diseases: expression in diseased tissues and production by human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
J Periodontal Res; 2008 Aug; 43(4):471-7. PubMed ID: 18557811
[TBL] [Abstract][Full Text] [Related]
29. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice.
Yoneyama H; Harada A; Imai T; Baba M; Yoshie O; Zhang Y; Higashi H; Murai M; Asakura H; Matsushima K
J Clin Invest; 1998 Dec; 102(11):1933-41. PubMed ID: 9835618
[TBL] [Abstract][Full Text] [Related]
30. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine.
Imai T; Nagira M; Takagi S; Kakizaki M; Nishimura M; Wang J; Gray PW; Matsushima K; Yoshie O
Int Immunol; 1999 Jan; 11(1):81-8. PubMed ID: 10050676
[TBL] [Abstract][Full Text] [Related]
31. Roxithromycin suppresses involucrin expression by modulation of activator protein-1 and nuclear factor-kappaB activities of keratinocytes.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Iizuka H
J Dermatol Sci; 2005 Sep; 39(3):175-82. PubMed ID: 16140218
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin.
Komine M; Kakinuma T; Kagami S; Hanakawa Y; Hashimoto K; Tamaki K
J Invest Dermatol; 2005 Sep; 125(3):491-8. PubMed ID: 16117790
[TBL] [Abstract][Full Text] [Related]
33. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions.
Vestergaard C; Yoneyama H; Murai M; Nakamura K; Tamaki K; Terashima Y; Imai T; Yoshie O; Irimura T; Mizutani H; Matsushima K
J Clin Invest; 1999 Oct; 104(8):1097-105. PubMed ID: 10525048
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal regulation of thymus and activation-regulated chemokine/macrophage-derived chemokine production by interleukin (IL)-4/IL-13 and interferon-gamma in HaCaT keratinocytes is mediated by alternations in E-cadherin distribution.
Fujii-Maeda S; Kajiwara K; Ikizawa K; Shinazawa M; Yu B; Koga T; Furue M; Yanagihara Y
J Invest Dermatol; 2004 Jan; 122(1):20-8. PubMed ID: 14962085
[TBL] [Abstract][Full Text] [Related]
35. Suppressive effects of Houttuynia cordata Thunb (Saururaceae) extract on Th2 immune response.
Lee JS; Kim IS; Kim JH; Kim JS; Kim DH; Yun CY
J Ethnopharmacol; 2008 Apr; 117(1):34-40. PubMed ID: 18325701
[TBL] [Abstract][Full Text] [Related]
36. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.
Perros F; Hoogsteden HC; Coyle AJ; Lambrecht BN; Hammad H
Allergy; 2009 Jul; 64(7):995-1002. PubMed ID: 19630858
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
[TBL] [Abstract][Full Text] [Related]
38. Circulating levels of both Th1 and Th2 chemokines are elevated in patients with sarcoidosis.
Nureki S; Miyazaki E; Ando M; Ueno T; Fukami T; Kumamoto T; Sugisaki K; Tsuda T
Respir Med; 2008 Feb; 102(2):239-47. PubMed ID: 17949965
[TBL] [Abstract][Full Text] [Related]
39. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides.
Shimauchi T; Sugita K; Nishio D; Isoda H; Abe S; Yamada Y; Hino R; Ogata M; Kabashima K; Tokura Y
J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665
[TBL] [Abstract][Full Text] [Related]
40. T cell chemokine receptor expression in human Th1- and Th2-associated diseases.
Campbell JD; HayGlass KT
Arch Immunol Ther Exp (Warsz); 2000; 48(6):451-6. PubMed ID: 11197598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
